Galectin Therapeutics (PHPN) Q3 2023 Earnings Report
DE:PHPN Q3 2023 EPS Results
- Actual EPS
- -EUR 0.21
- Consensus EPS
- -EUR 0.09
- Beat/Miss
- Missed by -EUR 0.13
- One Year Ago EPS
- -EUR 0.13
DE:PHPN Q3 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/13/2023
- Time
- Before Open
- Conference Call
- Monday, November 13, 2023
DE:PHPN Upcoming Earnings
Galectin Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q3 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PHPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.04- | -0.12 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -0.08-0.13 | -0.11 | -16.67% (-0.02) | |
| May 15, 2026 | 2026 (Q1) | ―-0.07 | -0.13 | 46.67% (+0.06) | |
| Mar 31, 2026 | 2025 (Q4) | -0.05-0.07 | -0.13 | 46.67% (+0.06) | |
| Nov 14, 2025 | 2025 (Q3) | -0.10-0.12 | -0.16 | 27.78% (+0.04) | |
| Aug 14, 2025 | 2025 (Q2) | -0.14-0.11 | -0.18 | 40.00% (+0.07) | |
| May 15, 2025 | 2025 (Q1) | ―-0.13 | -0.17 | 21.05% (+0.04) | |
| Mar 31, 2025 | 2024 (Q4) | -0.18-0.13 | -0.17 | 21.05% (+0.04) | |
| Nov 14, 2024 | 2024 (Q3) | -0.18-0.16 | -0.21 | 25.00% (+0.05) | |
| Aug 13, 2024 | 2024 (Q2) | -0.14-0.18 | -0.13 | -33.33% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
